| WAP-2044611-3/24/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| WAP-2044611-3/25/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| WAP-2044611-3/26/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| WAP-2044611-3/27/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| WAP-2044611-3/29/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| WAP-2044611-3/30/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| WAP-2044611-3/42/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| WAP-2044611-3/51/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| WAP-2044611-3/52/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| 112-4941542-8/1/1 — Lebkuchen-Schmidt GmbH & Co. KG | Nov 30, 2011 — Human Foods |
| UPS-6643282-7/1/1 — Angiomed GmbH & Co. Medizintechnik KG | Nov 29, 2011 — Devices |
| 100-8839768-1/3/4 — Windel GmbH & Co. KG | Nov 28, 2011 — Human Foods |
| 112-4478928-0/1/1 — Lebkuchen-Markt | Nov 25, 2011 — Human Foods |
| M21-0744632-2/2/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744632-2/1/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744632-2/6/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744632-2/5/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744632-2/8/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744632-2/9/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744632-2/4/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744632-2/3/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744632-2/7/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Human Foods |
| M21-0744666-0/1/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744666-0/2/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744666-0/2/2 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744666-0/5/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744666-0/2/3 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744666-0/4/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| M21-0744666-0/3/1 — Wendt-Chemie Vertriebsges Mbh & Co. | Nov 23, 2011 — Drugs and Biologics |
| 112-4636854-7/17/1 — A.W. Faber-Castell Cosmetics Gmbh | Nov 22, 2011 — Cosmetics |
| 112-4636854-7/17/2 — A.W. Faber-Castell Cosmetics Gmbh | Nov 22, 2011 — Cosmetics |
| UPS-3978859-7/21/1 — Beiersdorf AG | Nov 22, 2011 — Cosmetics |
| UPS-3978859-7/22/1 — Beiersdorf AG | Nov 22, 2011 — Cosmetics |
| UPS-3978859-7/23/1 — Beiersdorf AG | Nov 22, 2011 — Cosmetics |
| 112-4731135-5/1/1 — Infai Gmbh | Nov 21, 2011 — Devices |
| UPS-4336554-9/4/1 — A.W. Faber-Castell Cosmetics Gmbh | Nov 17, 2011 — Cosmetics |
| 112-4586106-2/1/1 — Goedecke Ag | Nov 17, 2011 — Drugs and Biologics |
| 701-5130776-9/1/1 — Innolight Gmbh | Nov 17, 2011 — Devices |
| 112-4442140-5/1/1 — Sankyo Pharma | Nov 16, 2011 — Cosmetics |
| 112-4147514-9/1/1 — Glaxosmithkline | Nov 16, 2011 — Cosmetics |
| EDX-0009549-7/1/1 — Troge Medical Gmbh | Nov 15, 2011 — Devices |
| EDX-0009549-7/2/1 — Troge Medical Gmbh | Nov 15, 2011 — Devices |
| 112-4144675-1/1/1 — Novartis Pharma | Nov 15, 2011 — Drugs and Biologics |
| 112-4034230-8/4/1 — Werbeprasente Hauptfleisch Gmbh | Nov 14, 2011 — Radiological Health |
| BNW-0127376-3/2/1 — Johann Wilhelm Von Eicken GmbH | Nov 10, 2011 — Tobacco Products |
| BER-4064595-2/1/1 — BASF SE | Nov 9, 2011 — Drugs and Biologics |
| 101-9592952-5/1/1 — Ascenion Gmbh | Nov 9, 2011 — Drugs and Biologics |
| UPS-4040269-1/1/1 — Peter Gulow | Nov 8, 2011 — Drugs and Biologics |
| UPS-4040269-1/1/4 — Peter Gulow | Nov 8, 2011 — Drugs and Biologics |
| UPS-4040269-1/1/3 — Peter Gulow | Nov 8, 2011 — Drugs and Biologics |